Miho Akimoto

2.5k citations

43 papers · 2.0k indexed · 1 hit paper · h-index 16

Co-authors: Keizo Takenaga Yoshio Honma Jun‐Ichi Hayashi Nobuko Koshikawa Kazuto Nakada Kaori Ishikawa Aya Yamaguchi Hirotake Imanishi
Topics: Cancer, Hypoxia, and Metabolism (7 papers)Eosinophilic Esophagitis (6 papers)IL-33, ST2, and ILC Pathways (6 papers)
Cited by: Cancer Research Clinical Biochemistry Molecular Biology
Journals: Science Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: Japan Pakistan United States

In The Last Decade

Miho Akimoto

40 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis

2008 1.2k citations Kaori Ishikawa, Keizo Takenaga et al. Science profile →

Peers

Countries citing papers authored by Miho Akimoto

Since Specialization

Citations

This map shows the geographic impact of Miho Akimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miho Akimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miho Akimoto more than expected).

Fields of papers citing papers by Miho Akimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miho Akimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miho Akimoto. The network helps show where Miho Akimoto may publish in the future.

Co-authorship network of co-authors of Miho Akimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Miho Akimoto. A scholar is included among the top collaborators of Miho Akimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miho Akimoto. Miho Akimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Downregulation of sST2 , a decoy receptor for interleukin‐33, enhances subcutaneous tumor growth in murine pancreatic cancer cells 2025 ·FEBS Open Bio ·Miho Akimoto,Nobuko Koshikawa,Takao Morinaga,Mimi Tamamori‐Adachi,Atsushi Takatori,Keizo Takenaga	0
2	Hypoxia induces downregulation of the tumor-suppressive sST2 in colorectal cancer cells via the HIF–nuclear IL-33–GATA3 pathway 2023 ·Proceedings of the National Academy of Sciences ·Miho Akimoto,Takao Susa,Noriyuki Okudaira,Nobuko Koshikawa,Harumi Hisaki,Masayoshi Iizuka,Hiroko Okinaga,Keizo Takenaga,Tomoki Okazaki,Mimi Tamamori‐Adachi	7
3	A novel LncRNA PTH-AS upregulates interferon-related DNA damage resistance signature genes and promotes metastasis in human breast cancer xenografts 2022 ·Journal of Biological Chemistry ·Miho Akimoto,Takao Susa,Noriyuki Okudaira,Harumi Hisaki,Masayoshi Iizuka,Hiroko Okinaga,Tomoki Okazaki,Mimi Tamamori‐Adachi	6
4	MCT4 is induced by metastasis-enhancing pathogenic mitochondrial NADH dehydrogenase gene mutations and can be a therapeutic target 2021 ·Scientific Reports ·Keizo Takenaga,Nobuko Koshikawa,Miho Akimoto,Yasutoshi Tatsumi,Jason Lin,Makiko Itami,Hiroki Nagase	9
5	Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice 2021 ·Scientific Reports ·Keizo Takenaga,Miho Akimoto,Nobuko Koshikawa,Hiroki Nagase	14
6	Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model 2020 ·PLoS ONE ·Keizo Takenaga,Miho Akimoto,Nobuko Koshikawa,Hiroki Nagase	11
7	25(OH)D3 stimulates the expression of vitamin D target genes in renal tubular cells when Cyp27b1 is abrogated 2020 ·The Journal of Steroid Biochemistry and Molecular Biology ·(unknown),Takao Susa,Mimi Tamamori‐Adachi,Masayoshi Iizuka,Miho Akimoto,Hiroko Okinaga,Yoshihide Fujigaki,Shunya Uchida,Shigeru Shibata,Tomoki Okazaki	4
8	Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis 2018 ·Cell Death and Disease ·Miho Akimoto,Riruke Maruyama,Yasunari Kawabata,Yoshitsugu Tajima,Keizo Takenaga	87
9	Role of the IL-33/ST2L axis in colorectal cancer progression 2018 ·Cellular Immunology ·Miho Akimoto,Keizo Takenaga	30
10	Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer 2016 ·Cell Death and Disease ·Miho Akimoto,(unknown),Susumu Nakae,Hirohisa Saito,Keizo Takenaga	48
11	Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment 2016 ·Nature Communications ·Miho Akimoto,Riruke Maruyama,Hiroyuki Takamaru,Takahiro Ochiya,Keizo Takenaga	84
12	Anticancer Effect of Ginger Extract against Pancreatic Cancer Cells Mainly through Reactive Oxygen Species-Mediated Autotic Cell Death 2015 ·PLoS ONE ·Miho Akimoto,(unknown),(unknown),Masato Yoshida,Keizo Takenaga	127
13	Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells 2012 ·Clinical & Experimental Metastasis ·(unknown),Miho Akimoto,(unknown),Tsuneo Tanaka,Yoshitsugu Tajima,Yoshio Honma,Keizo Takenaga	69
14	Cyclopamine induces eosinophilic differentiation and upregulates CD44 expression in myeloid leukemia cells 2010 ·Leukemia Research ·Tsutomu Takahashi,Koshi Kawakami,(unknown),Miho Akimoto,Keizo Takenaga,Junji Suzumiya,Yoshio Honma	16
15	ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasisbreakdown → 2008 ·Science ·Kaori Ishikawa,Keizo Takenaga,Miho Akimoto,Nobuko Koshikawa,Aya Yamaguchi,Hirotake Imanishi,Kazuto Nakada,Yoshio Honma,Jun‐Ichi Hayashi	1158
16	Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture 2008 ·Leukemia ·(unknown),Miho Akimoto,Hiromasa Kiyota,Yuki Ishii,Hiroki Ishikura,Yoshio Honma	22
17	Therapeutic strategy using phenotypic modulation of cancer cells by differentiation‐inducing agents 2007 ·Cancer Science ·Yoshio Honma,Miho Akimoto	14
18	Generation of trans-mitochondrial mice carrying homoplasmic mtDNAs with a missense mutation in a structural gene using ES cells 2006 ·Human Molecular Genetics ·Atsuko Kasahara,Kaori Ishikawa,Makiko Yamaoka,Masahito Ito,Naoki Watanabe,Miho Akimoto,Akitsugu Sato,Kazuto Nakada,Hitoshi Endo,Yoko Suda,Shin-Ichi Aizawa,Jun‐Ichi Hayashi	59
19	Nuclear DNA but not mtDNA controls tumor phenotypes in mouse cells 2004 ·Biochemical and Biophysical Research Communications ·Miho Akimoto,Mamoru Niikura,(unknown),Hiromichi Yonekawa,Kazuto Nakada,Yoshio Honma,Jun‐Ichi Hayashi	32
20	Recombinant Interleukin-2-Expanded Tumor Infiltrating Lymphocytes from Human Renal Cell Cancer Do Not Exhibit Autologous Tumor Cell-Specific Cytotoxicity 1991 ·Urologia Internationalis ·Takuya Nishimura,Y. Terashima,(unknown),(unknown),(unknown),Go Kimura,(unknown),Miho Akimoto	6

About Miho Akimoto

Miho Akimoto is a scholar working on Cancer Research, Aging and Immunology, having authored 43 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), Eosinophilic Esophagitis (6 papers) and IL-33, ST2, and ILC Pathways (6 papers). The work is most often cited by research in Cancer Research (615 citations), Clinical Biochemistry (145 citations) and Molecular Biology (1.3k citations). Miho Akimoto has collaborated with scholars based in Japan, Pakistan and United States. Frequent co-authors include Keizo Takenaga, Yoshio Honma, Jun‐Ichi Hayashi, Nobuko Koshikawa, Kazuto Nakada, Kaori Ishikawa, Aya Yamaguchi, Hirotake Imanishi, Keizo Takenaga and Riruke Maruyama. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact